| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 08/07/2007 | US7253187 Heterocyclic inhibitors of ERK2 and uses thereof |
| 08/07/2007 | US7253178 Carboxylic acids |
| 08/07/2007 | US7253174 (Anilino)(halo)pyrimidine derivatives or (anilino)(amino)pyrimidine derivatives; treating rheumatoid arthritis, psoriasis, Crohn's Disease, osteoarthritis or osteoporosis. |
| 08/07/2007 | US7253172 Enzyme inhibitor for treating a non-insulin dependent diabetes mellitus; 3-Amino-4-(3,4-difluorophenyl)butanoyl]-4-[2-({3-[(methylsulfonyl)amino]-phenyl}-amino)-2-oxoethyl]piperazin-2-yl}acetic acid |
| 08/07/2007 | US7253171 Antiinflammatory agents; immunology diseases; multiple sclerosis; antihistamines; antidiabetic agents; vision defects; antiarthritic agents; skin disorders; antitumor agents |
| 08/07/2007 | US7253155 Combination of a tetra-substituted pyrimidopyrimidine, and a corticosteroid simultaneously or within 14 days of each other |
| 08/07/2007 | US7253143 For treatment of urinary tract infections and inflammations, colitis, and candida infections of mucosal membranes; infant formula food containing the peptide |
| 08/07/2007 | US7252845 Synergistic compositions containing aromatic compounds and terpenoids present in Alpinia galanga |
| 08/07/2007 | US7252799 Methods for sterilizing preparations containing albumin |
| 08/07/2007 | CA2376379C Modified chimeric polypeptides with improved pharmacokinetic properties |
| 08/07/2007 | CA2369810C Method of treating pain |
| 08/07/2007 | CA2340636C Combinations of tetracyclic cyclic gmp-specific phosphodiesterase inhibitors with further therapeutic agents |
| 08/07/2007 | CA2332007C Adenosine a3 receptor modulators |
| 08/07/2007 | CA2317589C Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors |
| 08/07/2007 | CA2301799C Novel conjugates of opioids and endogenous carriers |
| 08/07/2007 | CA2289196C Sustained-release delayed gels |
| 08/07/2007 | CA2207804C Amides of mono and bicarboxylic acids with amino acids or glycosamines, selectively active on the cannabinoid peripheral receptor |
| 08/07/2007 | CA2192360C Bicyclic lactam inhibitor of interleukin-1-beta converting enzyme |
| 08/02/2007 | WO2007087154A2 Methods for enhancing therapeutic effects of a neurotoxin |
| 08/02/2007 | WO2007086584A1 NOVEL INHIBITOR OF FabK AND FabI/K |
| 08/02/2007 | WO2007086545A1 Method for screening cell function regulator |
| 08/02/2007 | WO2007086493A1 Medicine for transnasal administration |
| 08/02/2007 | WO2007086457A1 Quickly disintegrating tablet produced by direct dry-tabletting |
| 08/02/2007 | WO2007085629A2 Use of hyaluronic acid as a carrier molecule for?different classes of therapeutic active agents |
| 08/02/2007 | WO2007085357A1 Cyclourea compounds as calcium channel blockers |
| 08/02/2007 | WO2007085087A1 Vasopressin pathway polymorphisms as indicators of subject outcome in critically ill subjects |
| 08/02/2007 | WO2007065684A3 Bicyclic heteroyclic compounds as antiinflammatory or antiallergic agents |
| 08/02/2007 | WO2007059950A3 Dry powder pharmaceutical formulations of purine a2a agonists |
| 08/02/2007 | WO2007059905A3 Thienopyrimidines treating inflammatory diseases |
| 08/02/2007 | WO2007057691A3 Therapeutic uses of steroidal compounds |
| 08/02/2007 | WO2007045927A3 Therapeutic agent |
| 08/02/2007 | WO2007036900A3 Herbal composition for inflammatory disorders |
| 08/02/2007 | WO2007007095A3 Pharmaceutical compositions comprising a tgf-beta superfamily member |
| 08/02/2007 | US20070179297 Chemical compounds |
| 08/02/2007 | US20070179187 nor-seco himbacine derivatives; thrombosis, anticoagulants, anticancer agents; antiinflammatory agents; anticholesterol agents; cardiovascular disorders; antiarrhythmia agents; antiischemic agents; strokes; antiarthritic agents |
| 08/02/2007 | US20070179183 N-(2-phenylethyl)sulfamide derivatives as integrin alpha4 antagonists |
| 08/02/2007 | US20070179158 2,6-Disubstituted piperiddines as modulators |
| 08/02/2007 | US20070179153 Derivatives of heterocycles with 5 members, their preparation and their use as medicaments |
| 08/02/2007 | US20070179150 Nitrosated proton pump inhibitors, compositions and methods of use |
| 08/02/2007 | US20070179132 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 08/02/2007 | US20070179124 Substituted Porphyrins |
| 08/02/2007 | US20070179118 Use as inhibitors of cyclin-dependent kinases 4 (cdk4); treating proliferative disorders such as cancer; salt of 6-acetyl-8-cyclopentyl-5-methyl-2-(5-piperazin-1-yl-pyridin-2-ylamino)-8H-pyrido[2,3-d]pyrimidin-7-one for example |
| 08/02/2007 | US20070178551 Methods for producing modified glycoproteins |
| 08/02/2007 | US20070178091 Combination Therapy |
| 08/02/2007 | US20070178052 Delivery of opioids through an inhalation route |
| 08/02/2007 | DE102006002649A1 New aza-heterocycle compounds are tyrosine kinase inhibitors useful to treat and/or prevent e.g. cancer, tumor growth, tumor angiogenesis, arteriosclerosis, diabetic retinopathy and inflammation diseases |
| 08/02/2007 | CA2640159A1 Use of hyaluronic acid as a carrier molecule for different classes of therapeutic active agents |
| 08/02/2007 | CA2638773A1 Vasopressin pathway polymorphisms as indicators of subject outcome in critically ill subjects |
| 08/01/2007 | EP1813671A1 Soluble protein and utilization of the same |
| 08/01/2007 | EP1813626A1 Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof, antigens recognized thereby and cells obtained thereby |
| 08/01/2007 | EP1813623A1 Purinenucleoside derivative modified in 8-position and medicinal use thereof |
| 08/01/2007 | EP1813285A1 Preventive or therapeutic agent for neuropathic pain |
| 08/01/2007 | EP1813278A1 Nucleoside analogs with carboxamidine modified monocyclic base |
| 08/01/2007 | EP1813269A1 TRANSCRIPTIONAL FACTOR Nrf2 ACTIVATOR AND FOOD HAVING THE FUNCTION OF THE SAME IMPARTED THERETO |
| 08/01/2007 | EP1812451A2 Compounds and methods of use thereof |
| 08/01/2007 | EP1812442A2 Imidazo[1,2-a]pyrazin-8-ylamines useful as modulators of kinase activity |
| 08/01/2007 | EP1812439A2 Kinase inhibitors |
| 08/01/2007 | EP1812434A2 1,7-naphthyridines as pde4 inhibitors |
| 08/01/2007 | EP1812405A1 Novel bradykinin b1 antagonists, method for producing the same and the use thereof as drugs |
| 08/01/2007 | EP1812114A2 Ecteinascidin compounds as anti-inflammatory agents |
| 08/01/2007 | EP1812113A1 Pyrimidine compounds as histamine modulators |
| 08/01/2007 | EP1811999A1 Quinuclidine derivatives and their use as muscarinic m3 receptor antagonists |
| 08/01/2007 | EP1811985A1 Nutrient supplement and use of the same |
| 08/01/2007 | EP1811846A2 Methods for making and using synergistic multifunctional compositions |
| 08/01/2007 | EP1811845A2 Substituted biaryl quinolin-4-ylamine analogues |
| 08/01/2007 | EP1565456A4 1,2,4-triazole derivative, method for preparing the same, and pharmaceutical composition containing the same |
| 08/01/2007 | EP1546130B1 Piperidine derivatives for use in the treatment of chemokine mediated disease states |
| 08/01/2007 | EP1507760B1 Cyanoguanidine prodrugs |
| 08/01/2007 | EP1461326B1 Benzothiazole- and benzoxazole-4,7-dione derivatives and their use as cdc25 phosphatase inhibitors |
| 08/01/2007 | EP1461038B1 Arylsulfonamide derivatives for use as ccr3 antagonists in the treatment of inflammatory and immunological disorders |
| 08/01/2007 | EP1419158B1 Pteridinone derivatives as modulators of chemokine receptor activity |
| 08/01/2007 | EP1294714B1 Thrombin receptor antagonists |
| 08/01/2007 | EP1259235B1 Tyrosine kinase inhibitors |
| 08/01/2007 | EP1187592B1 Alpha v integrin receptor antagonists |
| 08/01/2007 | EP1007537B1 Receptor protein designated 2f1 |
| 08/01/2007 | EP0929310B1 Diagnostic and therapeutic methods related to regulating energy mobilization with ob protein and ob antibodies |
| 08/01/2007 | EP0884947B1 Dna vaccination for induction of suppressive t cell response |
| 08/01/2007 | CN1329409C Modulation of the expression of genes dependent on STAT-1 |
| 08/01/2007 | CN1329392C Substituted pyrazoles |
| 08/01/2007 | CN1329388C 1,3,5-triazine derivatives as ligands for human adenosine-A3 receptors |
| 08/01/2007 | CN1329374C Compound as CCR5 agonist |
| 08/01/2007 | CN1329372C Diaryl sulfide derivative, addition salt thereof, and immunosuppressant |
| 08/01/2007 | CN1329359C Ether compounds, compositions, and uses thereof |
| 08/01/2007 | CN1329082C Polymer conjugates of interferon beta-1a and their uses |
| 08/01/2007 | CN1329076C Plaster for orthopaedics and its preparation method |
| 08/01/2007 | CN1329075C Preparation method of ready prepared chinese medicinal granules for treathing pains |
| 08/01/2007 | CN1329074C Pandanguo medicated liquor |
| 08/01/2007 | CN1329071C Medicine composition for treating lumbago, leg and arm pain and generalized pain, and preparation method thereof |
| 08/01/2007 | CN1329064C Copper battledore medicated liquor |
| 08/01/2007 | CN1329063C Medicated liquor of stephania japonica miers |
| 08/01/2007 | CN1329058C Medicated liquor of cortex Zanthoxyli podocarpi |
| 08/01/2007 | CN1329057C Medicated liqor of Radix Oenotherae Erythrosepalae |
| 08/01/2007 | CN1329055C Mantuoluozi medicinal liquor |
| 08/01/2007 | CN1329054C Lopseed-root medicated liquor |
| 08/01/2007 | CN1329052C Medicated lanceolarium Roxb medicated liquor |
| 08/01/2007 | CN1329051C Luoshiteng medicated liquor |
| 08/01/2007 | CN1329048C Compound lotus plumule oral liquor |
| 08/01/2007 | CN1329046C Daoshenglian medicated liquor |
| 08/01/2007 | CN1329029C Painless injectable compositions containing salt of 2-arylpropionic acids |
| 08/01/2007 | CN101010302A Sigma receptor inhibitors |